Get the Stockscreener App
0.6758
0.53%
-0.0036
Palisade Bio Inc stock is traded at $0.6758, with a volume of 79,589.
It is down -0.53% in the last 24 hours and down -38.00% over the past month.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
See More
Previous Close:
$0.6794
Open:
$0.6903
24h Volume:
79,589
Relative Volume:
0.04
Market Cap:
$6.16M
Revenue:
-
Net Income/Loss:
$-14.07M
P/E Ratio:
-0.0483
EPS:
-13.99
Net Cash Flow:
$-12.56M
1W Performance:
-10.37%
1M Performance:
-38.00%
6M Performance:
-17.99%
1Y Performance:
-81.23%
1-Day Range:
$0.66
$0.6903
1-Week Range:
$0.6498
$0.754
52-Week Range:
$0.60
$4.318
Palisade Bio Inc Stock (PALI) Company Profile
Name
Palisade Bio Inc
Sector
Industry
Phone
(858) 704-4900
Address
7750 EL CAMINO REAL, SUITE 5200, CARLSBAD
Compare PALI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PALI
Palisade Bio Inc
|
0.6758 | 6.33M | 0 | -14.07M | -12.56M | -13.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Palisade Bio Inc Stock (PALI) Latest News
Has Palisade Bio Inc. found a price floor2025 Analyst Calls & Verified Entry Point Detection - Newser
Volatility clustering patterns for Palisade Bio Inc.2025 Market Sentiment & Weekly Stock Breakout Alerts - Newser
Sentiment analysis tools applied to Palisade Bio Inc.Trade Entry Summary & Detailed Earnings Play Strategies - Newser
Predicting Palisade Bio Inc. trend using moving averagesJuly 2025 Momentum & Low Risk Investment Opportunities - Newser
Tools to assess Palisade Bio Inc.’s risk profileEarnings Growth Report & Free Fast Gain Swing Trade Alerts - Newser
Will Palisade Bio Inc. rebound enough to break evenEarnings Beat & AI Optimized Trade Strategies - Newser
Quantitative breakdown of Palisade Bio Inc. recent moveWeekly Trend Recap & Verified Stock Trade Ideas - Newser
Measuring Palisade Bio Inc.’s beta against major indicesRate Cut & Long-Term Capital Growth Strategies - Newser
Multi factor analysis applied to Palisade Bio Inc.2025 Volatility Report & Verified Entry Point Detection - Newser
When is the best time to exit Palisade Bio Inc.Quarterly Portfolio Summary & Long-Term Safe Investment Plans - Newser
Applying Wyckoff theory to Palisade Bio Inc. stockWall Street Watch & Risk Managed Investment Signals - Newser
Chart overlay techniques for tracking Palisade Bio Inc.Market Volume Summary & Community Consensus Stock Picks - Newser
Real time scanner hits for Palisade Bio Inc. explained2025 Top Decliners & Weekly Return Optimization Plans - Newser
Is Palisade Bio Inc. forming a bottoming baseJuly 2025 News Drivers & AI Powered Market Entry Ideas - Newser
Palisade Bio Inc. stock volume spike explained2025 Market WrapUp & Community Trade Idea Sharing - Newser
Full technical analysis of Palisade Bio Inc. stockJuly 2025 Decliners & Expert Approved Momentum Trade Ideas - Newser
Is Palisade Bio Inc. backed by strong institutional buyingQuarterly Portfolio Summary & Daily Oversold Bounce Ideas - sundaytimes.kr
Can you recover from losses in Palisade Bio Inc.2025 EndofYear Setup & Verified Chart Pattern Signals - Newser
Order flow analysis tools used on Palisade Bio Inc.Market Trend Report & Reliable Price Breakout Alerts - Newser
Palisade Bio Inc Stock (PALI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.96%
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):